Pfizer Is Using AI to Discover Breakthrough Medicines

(Source: Pfizer)

Breakthrough therapies require breakthrough technologies. That’s why Pfizer scientists have been using artificial intelligence and supercomputing to bring new vaccines and medicines, like the oral COVID-19 treatment PAXLOVID™ (nirmatrelvir [PF-07321332] tablets and ritonavir tablets), to patients faster.

Instead of doing experiments in a physical lab setting, researchers can now use cloud-based supercomputing with AI machine learning models to test a manageable fraction of the millions of compounds that might work as a new drug, said Lidia Fonseca, Pfizer’s Chief Digital and Technology Officer.

Researchers can then focus on the compounds with the highest chance of becoming medicines and potentially reduce the time it takes to bring breakthrough therapies to patients.